Free. Unsubscribe any time.
Taysha Gene Therapies, Inc. (TSHA)
Taysha Gene Therapies, Inc. filed 4 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 1 reporting owner, covering 4 transactions and 800,000 shares. None carries the SEC's AFF10B5ONE flag; all 4 name a plan in a footnote. 7 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-07-10, came 88 days after the one before it (2026-04-13) and reports 1 transaction against 3 in the filing before it.
- The sales it reports total 200,000 shares, the same as the 200,000 in the filing before it.
- Its 4 plan statements rank 464th of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 6 have more plan statements on file than it and 4 have fewer.
- Its 4 filings on file run from 2025-09-12 to 2026-07-10, and state one plan adoption date, 2025-06-11.
Trades in Taysha Gene Therapies, Inc. 4
- Nagendran Sukumar — 2025-09-10 · S · 200,000 shares
- Nagendran Sukumar — 2026-01-12 · S · 200,000 shares
- Nagendran Sukumar — 2026-04-10 · S · 200,000 shares
- Nagendran Sukumar — 2026-07-10 · S · 200,000 shares
Adoption dates in Taysha Gene Therapies, Inc. 1
- 2025-06-11 — stated in 4 filings
Results prints in Taysha Gene Therapies, Inc. 7
- 2025-02-26
- 2025-05-15
- 2025-08-12
- 2025-11-04
- 2026-03-19
- 2026-05-06
- 2026-08-11
Trades before a print in Taysha Gene Therapies, Inc. 0
- 26 days before the 2026-05-06 print — 2026-04-10 · S · Nagendran Sukumar · 200,000 shares
- 32 days before the 2026-08-11 print — 2026-07-10 · S · Nagendran Sukumar · 200,000 shares
- 55 days before the 2025-11-04 print — 2025-09-10 · S · Nagendran Sukumar · 200,000 shares
- 66 days before the 2026-03-19 print — 2026-01-12 · S · Nagendran Sukumar · 200,000 shares
Interval to Taysha Gene Therapies, Inc.’s next reported results date
How the interval and sources are counted →
- 0within 5 days
- 0within 10 days
- 26shortest, days
- 0no later print
Adoption dates Taysha Gene Therapies, Inc. states
- 2025-06-11 in 4 filings
Filing text: “10b5-1 trading plan adopted by the Reporting Person on June 11, 2025”
Reported results dates on file
- 2025-02-26
- 2025-05-15
- 2025-08-12
- 2025-11-04
- 2026-03-19
- 2026-05-06
- 2026-08-11
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.